U

Director Director DIN 05205708
DIN 05205708 First appointment Feb 2012 Primary industry Trading
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Feb 2012
Shareholding value β€’β€’β€’β€’ Premium profile

About Ujjwal

Data last updated:

Ujjwal was a Director at Sheraton Pharmaceuticals Private Limited (2015–2019) and Director at Horizon Biotech Private Limited (from 2012). The companies operate in Trading.

DIN 05205708
Primary Designation Director
Industry Trading
First Appointment 20 Feb 2012
Oldest Company Age 14 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director24 Mar 20152015₹2.2 Lakh (FY 2017)Active
Horizon Biotech Private Limited U85110BR2012PTC018202
Director20 Feb 20122012Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Horizon Biotech Private Limited
Sheraton Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Ujjwal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ujjwal

Ujjwal was first appointed on 20 Feb 2012 as Director at Horizon Biotech Private Limited. The most recent appointment on record is 24 Mar 2015 at Sheraton Pharmaceuticals Private Limited.

Ujjwal held 2 earlier board appointments: Sheraton Pharmaceuticals Private Limited (Director, 24 Mar 2015 to 25 May 2019); Horizon Biotech Private Limited (Director, from 20 Feb 2012).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available